A cluster randomised trial evaluating the clinical effectiveness and cost of telemedicine delivered multidisciplinary meetings in breast cancer

ISRCTN ISRCTN67592929
DOI https://doi.org/10.1186/ISRCTN67592929
Secondary identifying numbers 1217319
Submission date
13/09/2005
Registration date
11/11/2005
Last edited
09/05/2012
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Cancer
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Ian Kunkler
Scientific

Oncology Department
Western General Hospital
Crewe Road South
Edinburgh
EH4 2XU
United Kingdom

Phone +44 (0)131 537 2213
Email iankunkler@yahoo.com

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Participant information sheet Not available in web format, please use the contact details below to request a patient information sheet
Scientific title
Study acronymTELEMAM
Study objectivesDecision making in breast cancer management at a multidisciplinary team (MDT) meeting is as clinically effective as face-to-face meetings and achieved at lower cost.
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedBreast cancer
InterventionRandomised standard face-to-face 'on site' multidisciplinary meetings for breast cancer management (MDTs) at Dumfries and Dunfermline (Arm 1) versus MDTs on Dumfries and Dunfermline patients linked by telemedicine between Dumfries and Edinburgh, and Dunfermline and Edinburgh (Arm 2).
Intervention typeOther
Primary outcome measure1. Satisfaction with communication process of multidisciplinary decision making for each patient (Interpersonal Communication Satisfaction Scale)
2. Costs of face-to-face and telemedicine delivered decision making
3. Compliance with Scottish Intercollegiate Guidelines Network (SIGN) guidelines of best practice for breast cancer
Secondary outcome measures1. Pre- and post-trial attitudes to face-to-face and telemedicine delivered multidisciplinary clinics (Personal Report of Communication Apprehension)
2. Measures of objective patterns of interaction
3. Subjective measures of interaction (Group Behaviour Questionnaire, Group Behaviour Inventory, Group Dimensions Description Questionnaire)
4. Communication content (Interaction Process Analysis)
5. General dimensions of output (satisfaction with communication, group atmosphere, involvement, trust and agreement)
Overall study start date24/04/2003
Completion date31/07/2005

Eligibility

Participant type(s)Patient
Age groupAdult
SexFemale
Target number of participants230
Key inclusion criteria1. Histologically proven breast cancer
2. Requiring decision on treatment of primary or recurrent breast cancer
Key exclusion criteriaDoes not match inclusion criteria
Date of first enrolment24/04/2003
Date of final enrolment31/07/2005

Locations

Countries of recruitment

  • Scotland
  • United Kingdom

Study participating centre

Oncology Department
Edinburgh
EH4 2XU
United Kingdom

Sponsor information

UK Department of Health Research and Development
Government

Dr R Curry and Mr W Maton-Howarth
Department of Health Research and Development
Richmond House
79 Whitehall
London
SW1A 2NL
United Kingdom

Phone +44 (0)207 210 4850
Email richard.curry@imperial.ac.uk
Website http://www.dh.gov.uk

Funders

Funder type

Government

Department of Health (UK) - Research and Development

No information available

Big Lottery Fund (UK)
Private sector organisation / Other non-profit organizations
Alternative name(s)
BIG
Location
United Kingdom

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Protocol article protocol 01/10/2005 Yes No
Results article results 01/11/2007 Yes No